Related Experiment Video
Updated: Feb 5, 2026

Ex Vivo Treatment Response of Primary Tumors and/or Associated Metastases for Preclinical and Clinical Development of Therapeutics
Published on: October 2, 2014
Treatment resistant schizophrenia: Clinical, biological, and therapeutic perspectives
Frederick C Nucifora1, Edgar Woznica1, Brian J Lee1
1Department of Psychiatry and Behavioral Sciences, Johns Hopkins Hospital, 600 N. Wolfe St., Baltimore, MD 21287, USA.
Abstract:
Treatment resistant schizophrenia (TRS) refers to the significant proportion of schizophrenia patients who continue to have symptoms and poor outcomes despite treatment. While many definitions of TRS include failure of two different antipsychotics as a minimum criterion, the wide variability in inclusion criteria has challenged the consistency and reproducibility of results from studies of TRS. We begin by reviewing the clinical, neuroimaging, and neurobiological characteristics of TRS. We further review the current treatment strategies available, addressing clozapine, the first-line pharmacological agent for TRS, as well as pharmacological and non-pharmacological augmentation of clozapine including medication combinations, electroconvulsive therapy, repetitive transcranial magnetic stimulation, deep brain stimulation, and psychotherapies. We conclude by highlighting the most recent consensus for defining TRS proposed by the Treatment Response and Resistance in Psychosis Working Group, and provide our overview of future perspectives and directions that could help advance the field of TRS research, including the concept of TRS as a potential subtype of schizophrenia.
Insights
Treatment resistant schizophrenia (TRS) remains a challenge, with varied definitions impacting research. This review covers TRS characteristics, treatments like clozapine, and proposes a new consensus definition for advancing research.
Area of Science:
- Neuroscience
- Psychiatry
- Clinical Research
Background:
- Treatment resistant schizophrenia (TRS) affects a significant patient population, characterized by persistent symptoms despite adequate antipsychotic trials.
- Inconsistent definitions of TRS hinder research reproducibility and clinical consistency.
- Understanding the clinical, neuroimaging, and neurobiological features of TRS is crucial.
Purpose of the Study:
- To review the clinical, neuroimaging, and neurobiological characteristics of Treatment Resistant Schizophrenia (TRS).
- To summarize current and emerging treatment strategies for TRS, including clozapine and augmentation therapies.
- To present the latest consensus on defining TRS and discuss future research directions.
Main Methods:
- Literature review of clinical studies, neuroimaging research, and neurobiological investigations related to TRS.
- Analysis of pharmacological (clozapine, augmentation) and non-pharmacological (ECT, TMS, DBS, psychotherapy) treatment modalities.
- Evaluation of proposed consensus criteria for defining TRS.
Main Results:
- TRS exhibits distinct clinical, neuroimaging, and neurobiological profiles.
- Clozapine is the established first-line treatment, with various augmentation strategies showing promise.
- A new consensus definition for TRS has been proposed to improve research consistency.
Conclusions:
- Standardizing the definition of TRS is essential for advancing research and clinical practice.
- A multimodal treatment approach, including clozapine and augmentation, is key for managing TRS.
- Future research should explore TRS as a potential distinct subtype of schizophrenia.
Related Concept Videos
Biological Causes of Schizophrenia
Genetic Factors in Schizophrenia
The genetic basis of schizophrenia is strongly supported by family and twin...
Changes in Skin Color: Clinical Perspectives
Albinism
Albinism is a genetic disorder that affects (completely or partially) the coloring of skin, hair, and eyes. The defect is primarily...
Treatment Resistant Cancers
Schizophrenia
Psychological and Sociocultural Causes of Schizophrenia
Psychodynamic Perspectives on Personality
Psychodynamic theorists argue that unconscious...

